Description :
MYBMIM is a novel peptidomimetic inhibitor. It can inhibit MYB and CREB-binding protein (CBP) in acute myeloid leukemia (AML) cells.
Application :
the potential treatment of acute myeloid leukemia (AML)
More details are to be found
here